SCHEMBL17037201

SCHEMBL17037201

CCCCCCCCCC(C)(O)c1cn(CCCCO)nn1

nearest known ligand 0.60

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
SMPD1 P17405 4/20 0.60
GBA1 P04062 14/20 0.41
HRH4 Q9H3N8 1/20 0.36
HRH3 Q9Y5N1 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL616778 0.82 SMPD1 (0.67) SMPD1GBA1HRH4HRH3
SCHEMBL4224858 0.78 SMPD1 (0.66) SMPD1GBA1HRH4HRH3
SCHEMBL29520868 0.76 SMPD1 (0.71) SMPD1GBA1HRH4HRH3
SCHEMBL23081491 0.75 SMPD1 (0.57) SMPD1GBA1HRH4HRH3
SCHEMBL23064212 0.75 SMPD1 (1.00) SMPD1GBA1HRH4HRH3
SCHEMBL25329590 0.75 SMPD1 (1.00) SMPD1GBA1HRH4HRH3
SCHEMBL23064221 0.75 SMPD1 (1.00) SMPD1GBA1HRH4HRH3
SCHEMBL23064315 0.75 SMPD1 (1.00) SMPD1GBA1HRH4HRH3
SCHEMBL23064217 0.75 SMPD1 (1.00) SMPD1GBA1HRH4HRH3
SCHEMBL25329230 0.75 SMPD1 (1.00) SMPD1GBA1HRH4HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9376385-B2 Solid-phase supports and uses thereof INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) 2016-06-28 US disclosed
US-9376385-B2 Solid-phase supports and uses thereof INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) 2016-06-28 US disclosed
US-20150240006-A1 Solid-Phase Supports and Uses Thereof INDIANA UNIVERSITY RESEARCH & TECHNOLOGY CORPORATION 2015-08-27 US disclosed
US-20150240006-A1 Solid-Phase Supports and Uses Thereof INDIANA UNIVERSITY RESEARCH & TECHNOLOGY CORPORATION 2015-08-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150240006-A1 Solid-Phase Supports and Uses Thereof ACR, ALK, ALKBH3 SMPD1 1482/4885GBA1 1001/4885HRH4 3043/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.